Market Place
Sourcing Support
Aerie Announces Positive Phase 3 Topline Results for Netarsudil in Japan
12 Oct 2021 //
BUSINESSWIRE
Aerie Completes Enrollment of its first Phase 3 Clinical Trial of Netarsudil
17 Jun 2021 //
BUSINESSWIRE
Rho kinase inhibitor, "Ripasudil Hydrochloride Hydrate" INDapp for Ph2 clinical
03 Sep 2019 //
PR NEWSWIR
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.